ASYMMETRIC REACTIONS OF PROCHIRAL KETONES
ASYMMETRIC REACTIONS OF PROCHIRAL KETONES
批准号:
3466718
负责人:
Jeffrey Aube
金额:
$8.78万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-07-01 至 1993-06-30
中文摘要
影响光学合成的几种相关技术
提出了活性杂环。 这些方法,包括
利用非对映异构基团的选择性,可以分离成
两个普通类。
光学活性内酯的合成方案是基于
一种合成的不对称贝克曼
重排 在该方案中,将前手性酮(例如4-甲基-N-苯基-N-甲基-N
取代的环己酮或内消旋双环结构),
转化成在氮上带有手性取代基的亚胺,
然后将其立体特异性氧化成氧氮丙啶。 这些
然后材料进行立体定向重排反应,
在光解后,得到(在除去手性取代基后
对氮)对映体富集的内酰胺。
此外,对映体特异性去质子化和烯胺反应
为了在远端实现立体控制,
在所提出的基板中的立体中心。 这项技术可以
然后与标准插入相交(Beckmann,Baeyer,
产生具有取代基模式的杂环的化学
这是对上述方案所实现的目标的补充。
所提出的化学方法将应用于三类有机化合物
药物制剂,其中每一种都已被证明是生物学上的
活性或非活性取决于绝对构型:肉毒碱
和其他γ-氨基酸,苯并吗啡喃镇痛剂,
和育亨宾生物碱。
最后,提出了一种新的控制近-
将呈现对称的双键或环氧化物。
英文摘要
Several related techniques to effect the synthesis of optically
active heterocycles are proposed. These methods, which involve
the use of diastereotopic group selectivity, can be separated into
two general classes.
A scheme for the synthesis of optically active lactones is based on
a synthetic equivalent of an asymmetric Beckmann
rearrangement. In this plan, a prochiral ketone (such as a 4-
substituted cyclohexanone or a meso-bicyclic structure) is
converted into a imine bearing a chiral substituent on nitrogen,
which is then stereospecifically oxidized to an oxaziridine. These
materials then undergo a stereospecific rearrangement reaction
upon photolysis, affording (after removal of the chiral substituent
on nitrogen) enantiomerically enriched lactams.
In addition, enantiospecific deprotonations and enamine reactions
are proposed in order to effect stereocontrol at distal
stereocenters in the proposed substrates. This technology can
then intersect with standard insertion (Beckmann, Baeyer-
Villager) chemistry to yield heterocycles with substituent patterns
that are complementary to those achieved in the scheme above.
The chemistry proposed will be applied to three classes of organic
medicinal agents, each of which has been shown to be biologically
active or inactive depending on absolute configuration: carnitine
and other gamma-amino acids, the benzomorphinan analgesics,
and the yohimbine alkaloids.
Finally, a novel scheme to control regioselectivity on nearly-
symmetrical double bonds or epoxides will be presented.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Small Molecule Therapeutic Discovery for Angelman Syndrome
-
批准号:10636253
-
项目类别:
-
资助金额:$57.55万
-
财政年份:2023
-
负责人:Jeffrey Aube
-
依托单位:
Discovery of Phospopantetheinyl Transferse Inhibitors Against Mycobacterium tuberculosis
-
批准号:10450109
-
项目类别:
-
资助金额:$77.99万
-
财政年份:2021
-
负责人:Jeffrey Aube
-
依托单位:
UNC Chemical Biology Interface Training Program
-
批准号:10646465
-
项目类别:
-
资助金额:$27.01万
-
财政年份:2021
-
负责人:Jeffrey Aube
-
依托单位:
Discovery of Phospopantetheinyl Transferse Inhibitors Against Mycobacterium tuberculosis
-
批准号:10653027
-
项目类别:
-
资助金额:$77.84万
-
财政年份:2021
-
负责人:Jeffrey Aube
-
依托单位:
Discovery of Phospopantetheinyl Transferse Inhibitors Against Mycobacterium tuberculosis
-
批准号:10298705
-
项目类别:
-
资助金额:$80.77万
-
财政年份:2021
-
负责人:Jeffrey Aube
-
依托单位:
UNC Chemical Biology Interface Training Program
-
批准号:10089153
-
项目类别:
-
资助金额:$16.29万
-
财政年份:2021
-
负责人:Jeffrey Aube
-
依托单位:
UNC Chemical Biology Interface Training Program
-
批准号:10415825
-
项目类别:
-
资助金额:$26.4万
-
财政年份:2021
-
负责人:Jeffrey Aube
-
依托单位:
Novel Probes of the Kappa Opioid Receptor: Chemistry, Pharmacology, and Biology
-
批准号:9229013
-
项目类别:
-
资助金额:$68.4万
-
财政年份:2016
-
负责人:Jeffrey Aube
-
依托单位:
Novel Probes of the Kappa Opioid Receptor: Chemistry, Pharmacology, and Biology
-
批准号:9889913
-
项目类别:
-
资助金额:$63.8万
-
财政年份:2016
-
负责人:Jeffrey Aube
-
依托单位:
Novel Probes of the Kappa Opioid Receptor: Chemistry, Pharmacology, and Biology
-
批准号:9113893
-
项目类别:
-
资助金额:$72.1万
-
财政年份:2016
-
负责人:Jeffrey Aube
-
依托单位:
Molecular cancer therapy targeting HuR-ARE interaction
-
批准号:9297260
-
项目类别:
-
资助金额:$43.2万
-
财政年份:2015
-
负责人:Jeffrey Aube
-
依托单位:
Molecular cancer therapy targeting HuR-ARE interaction
-
批准号:8964473
-
项目类别:
-
资助金额:$43.2万
-
财政年份:2015
-
负责人:Jeffrey Aube
-
依托单位:
Molecular cancer therapy targeting HuR-ARE interaction
-
批准号:9069752
-
项目类别:
-
资助金额:$43.2万
-
财政年份:2015
-
负责人:Jeffrey Aube
-
依托单位:
Chemistry Core
-
批准号:10057814
-
项目类别:
-
资助金额:$76.63万
-
财政年份:2014
-
负责人:Jeffrey Aube
-
依托单位:
Small molecules modulating RNA-binding protein Msi1
-
批准号:8696948
-
项目类别:
-
资助金额:$43.25万
-
财政年份:2014
-
负责人:Jeffrey Aube
-
依托单位:
Structure and Function of Cytochrome P450 17A1
-
批准号:8636038
-
项目类别:
-
资助金额:$27.8万
-
财政年份:2012
-
负责人:Jeffrey Aube
-
依托单位:
Structure and Function of Cytochrome P450 17A1
-
批准号:8822310
-
项目类别:
-
资助金额:$26.44万
-
财政年份:2012
-
负责人:Jeffrey Aube
-
依托单位:
Structure and Function of Cytochrome P450 17A1
-
批准号:9326803
-
项目类别:
-
资助金额:$1.4万
-
财政年份:2012
-
负责人:Jeffrey Aube
-
依托单位:
Structure and Function of Cytochrome P450 17A1
-
批准号:8499381
-
项目类别:
-
资助金额:$26.78万
-
财政年份:2012
-
负责人:Jeffrey Aube
-
依托单位:
Structure and Function of Cytochrome P450 17A1
-
批准号:8913319
-
项目类别:
-
资助金额:$6.17万
-
财政年份:2012
-
负责人:Jeffrey Aube
-
依托单位:
国内基金
海外基金
Iboga alkaloids骨架导向的不对称串联反应构建吖庚环并[4,5-b]吲哚及其在全合成中的应用
-
批准号:21801032
-
项目类别:青年科学基金项目
-
资助金额:26.0万元
-
批准年份:2018
-
负责人:陈惠渝
-
依托单位: